Extracorporeal shock wave therapy for the treatment of angina
Ellery B, Mundy L, Hiller JE
Record ID 32011000608
English
Authors' recommendations:
Clinical studies of small sample size have been conducted on the basis of earlier promising results with animal studies for the application of SWT. It would appear that end-stage ischaemic heart disease patients who have exhausted other treatment options stand to experience at least moderate relief from symptoms of angina after a course of SWT with consequent improvement in daily living and less restrictions on physical activity. To date, the procedure has been shown to be safe within a 12 month follow-up period.Although this assessment was based on low-level evidence with a lack of long-term follow-up data, several randomised controlled trials are expected to be completed and their results published in the near future. It would be prudent to await the results of these trials as shock wave treatment is considered an option of last resort for patients who have exhausted all other treatment avenues. HealthPACT have therefore recommended that this technology be monitored for further information in 24-months time.
Details
Project Status:
Completed
Year Published:
2010
URL for published report:
Not Available
English language abstract:
An English language summary is available
Publication Type:
Not Assigned
Country:
Australia
MeSH Terms
- Angina Pectoris
- Lithotripsy
Contact
Organisation Name:
Adelaide Health Technology Assessment
Contact Address:
School of Public Health, Mail Drop 545, University of Adelaide, Adelaide SA 5005, AUSTRALIA, Tel: +61 8 8313 4617
Contact Name:
ahta@adelaide.edu.au
Contact Email:
ahta@adelaide.edu.au
Copyright:
Adelaide Health Technology Assessment (AHTA)
This is a bibliographic record of a published health technology assessment from a member of INAHTA or other HTA producer. No evaluation of the quality of this assessment has been made for the HTA database.